Meredith Kaya | VP, IR and Corporate Communications |
Mark Mallon | CEO |
Thomas McCourt | President |
Gina Consylman | SVP and CFO |
Michael Shetzline | CMO, SVP and Head of Drug Development |
Unidentified Analyst | Credit Suisse |
Eric Joseph | J.P. Morgan |
Boris Peaker | Cowen and Company |
Jacob Hughes | Wells Fargo |
Ladies and gentlemen, thank you for standing by and welcome to the Ironwood Pharmaceuticals Fourth Quarter and Full Year 2020 Investor Update Conference Call. At this time, all participants are in a listen-only mode. After the speakers’ presentation, there will be a question-and-answer session. [Operator Instructions]. I would now like to hand the conference over to your speaker today, Meredith Kaya.